Examining Erythrocytes as Potential Blood Biomarkers for Autism Spectrum Disorder: Their Relationship to Symptom

Tomas Jasenovec1, Dominika Radosinska2, Ivan Belica1

  • 1Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 2, 811 08 Bratislava, Slovakia.

Biomedicines
|November 27, 2024
PubMed

Insights

Autism spectrum disorder (ASD) severity in children is linked to red blood cell (RBC) properties like deformability and NO production. However, these RBC characteristics are not yet reliable biomarkers for diagnosing or predicting autism severity.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Hematology

Background:

  • Children with autism spectrum disorder (ASD) exhibit erythrocyte abnormalities.
  • Reduced red blood cell (RBC) deformability may impact brain function in ASD.
  • Nitric oxide (NO) and Na,K-ATPase activity are implicated in both RBC deformability and ASD.

Purpose of the Study:

  • To investigate associations between erythrocyte properties and autism severity.
  • To explore RBC parameters as potential biomarkers for ASD.

Main Methods:

  • 179 children with ASD were assessed using ADOS-2 and VABS-3.
  • RBC deformability was measured via filtration.
  • RBC nitric oxide (NO) production, Na,K-ATPase kinetics, and osmotic resistance were evaluated.

Main Results:

  • More severe ASD symptoms correlated with impaired RBC deformability and osmotic resistance.
  • Higher RBC NO production linked to better adaptive behavior and social affect scores.
  • Increased Na,K-ATPase affinity for sodium negatively correlated with restricted behaviors in ASD.

Conclusions:

  • Potential links exist between ASD severity and specific RBC properties.
  • RBC deformability, NO production, Na,K-ATPase kinetics, and osmotic resistance show associations with ASD.
  • These erythrocyte parameters were not sufficiently strong or consistent to serve as reliable diagnostic or prognostic biomarkers for ASD.
Abstract

Related Concept Videos